PubRank
Search
About
G W Stone
Author PubWeight™ 53.33
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
N Engl J Med
1993
6.52
2
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.
N Engl J Med
1999
4.37
3
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
N Engl J Med
2001
2.83
4
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices.
J Am Coll Cardiol
2001
2.74
5
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.
Circulation
1999
2.67
6
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry.
J Am Coll Cardiol
2001
1.74
7
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
J Am Coll Cardiol
2000
1.60
8
Late results of percutaneous transluminal coronary angioplasty of two or more major native coronary arteries.
Am J Cardiol
1994
1.46
9
Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty.
J Invasive Cardiol
2000
1.38
10
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials).
Am J Cardiol
2000
1.15
11
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial).
Am J Cardiol
2001
1.13
12
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results.
J Am Coll Cardiol
2001
1.12
13
Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients.
Circulation
2000
1.10
14
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial.
J Am Coll Cardiol
1999
1.05
15
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.
J Am Coll Cardiol
2001
1.03
16
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions.
Am J Cardiol
2000
1.02
17
Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality.
Circulation
1999
1.00
18
Preparation of alkylamine and 125I-radiolabeled derivatives of hyaluronic acid uniquely modified at the reducing end.
Anal Biochem
1984
0.96
19
Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.
Circulation
2001
0.92
20
Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system.
Neth Heart J
2010
0.91
21
Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial.
J Am Coll Cardiol
2001
0.89
22
Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results.
Am Heart J
2001
0.87
23
Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes.
J Am Coll Cardiol
2000
0.87
24
Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results.
Circulation
2000
0.86
25
Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (< 20 mm) stents.
J Am Coll Cardiol
2000
0.84
26
Extensive direct-tandem organization of a long repeat DNA sequence on the Y chromosome of chinook salmon (Oncorhynchus tshawytscha).
J Mol Evol
1998
0.84
27
Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role of early percutaneous revascularization.
J Am Coll Cardiol
1999
0.83
28
Interventional procedures in acute myocardial infarction.
Am Heart J
2001
0.81
29
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting.
Am J Cardiol
2001
0.81
30
Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions.
J Am Coll Cardiol
2000
0.81
31
Primary coronary angioplasty versus thrombolysis.
N Engl J Med
1997
0.80
32
Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging.
Circulation
1999
0.80
33
Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
Catheter Cardiovasc Interv
2000
0.80
34
Oxygen requirement for prostaglandin biosynthesis.
Prostaglandins Med
1978
0.79
35
Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators.
Lasers Surg Med
1998
0.78
36
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site.
Am J Cardiol
1999
0.78
37
Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts.
Am J Cardiol
2000
0.78
38
Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting.
Am J Cardiol
2001
0.78
39
Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
Am J Cardiol
2001
0.78
40
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial.
Arq Bras Cardiol
2001
0.77
41
Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Am J Cardiol
1996
0.77
42
Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting.
J Am Coll Cardiol
2000
0.76
43
Teratogenic effects of hyperthermia in the bonnet monkey (Macaca radiata).
Teratology
1979
0.76
44
Glycoprotein IIb/IIIa inhibitors: more different than alike?
Catheter Cardiovasc Interv
2001
0.75
45
Primary stenting in acute myocardial infarction: the promise and the proof.
Circulation
1998
0.75
46
Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty.
Am J Cardiol
2000
0.75
47
Primary mechanical reperfusion in acute myocardial infarction: the United States experience.
Semin Interv Cardiol
1999
0.75
48
Optimally deployed stents in the treatment of restenotic versus de novo lesions.
Am J Cardiol
2000
0.75
49
Interventional strategies for managing acute myocardial infarction.
Cardiol Clin
1994
0.75
50
Adverse influence of baroreceptor dysfunction on upright exercise in congestive heart failure.
Am J Med
1986
0.75
51
Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes.
J Am Coll Cardiol
2000
0.75
52
PAMI (Primary Angioplasty in Myocardial Infarction) Stent Pilot Trial.
Clin Cardiol
1998
0.75
53
Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization.
Am J Cardiol
2000
0.75